HABA Laboratories,Inc. (TYO:4925)
Japan
· Delayed Price · Currency is JPY 1,806.00
-19.00 (-1.04%)
Mar 10, 2026, 11:07 AM JST
HABA Laboratories,Inc. Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 4,824 | 4,743 | 3,959 | 4,817 | 5,651 | 5,663 | Upgrade
|
| Cash & Short-Term Investments | 4,824 | 4,743 | 3,959 | 4,817 | 5,651 | 5,663 | Upgrade
|
| Cash Growth | 20.18% | 19.80% | -17.81% | -14.76% | -0.21% | 8.32% | Upgrade
|
| Receivables | 1,081 | 1,196 | 1,259 | 975 | 1,126 | 1,200 | Upgrade
|
| Inventory | 2,938 | 2,921 | 3,713 | 3,368 | 3,151 | 4,034 | Upgrade
|
| Other Current Assets | 193 | 175 | 145 | 183 | 143 | 416 | Upgrade
|
| Total Current Assets | 9,036 | 9,035 | 9,076 | 9,343 | 10,071 | 11,313 | Upgrade
|
| Property, Plant & Equipment | 2,897 | 2,969 | 2,955 | 4,452 | 4,655 | 5,003 | Upgrade
|
| Long-Term Investments | 173 | 187 | 315 | 308 | 377 | 397 | Upgrade
|
| Other Intangible Assets | 84 | 93 | - | 315 | 346 | 522 | Upgrade
|
| Long-Term Deferred Tax Assets | 54 | 58 | 83 | 235 | 234 | 205 | Upgrade
|
| Other Long-Term Assets | 1 | 2 | 2 | 2 | 2 | 1 | Upgrade
|
| Total Assets | 12,245 | 12,344 | 12,431 | 14,655 | 15,685 | 17,441 | Upgrade
|
| Accounts Payable | 296 | 236 | 303 | 475 | 336 | 310 | Upgrade
|
| Short-Term Debt | 200 | 500 | 600 | 200 | 300 | 1,100 | Upgrade
|
| Current Portion of Long-Term Debt | 511 | 589 | 754 | 801 | 785 | 905 | Upgrade
|
| Current Income Taxes Payable | 817 | 943 | 701 | 869 | 792 | 780 | Upgrade
|
| Other Current Liabilities | 502 | 390 | 455 | 453 | 318 | 357 | Upgrade
|
| Total Current Liabilities | 2,326 | 2,658 | 2,813 | 2,798 | 2,531 | 3,452 | Upgrade
|
| Long-Term Debt | 749 | 727 | 1,000 | 1,031 | 1,472 | 1,913 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 45 | 2 | 50 | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 31 | 30 | 62 | 54 | 46 | 38 | Upgrade
|
| Total Liabilities | 3,151 | 3,417 | 3,925 | 3,883 | 4,049 | 5,403 | Upgrade
|
| Common Stock | 696 | 696 | 696 | 696 | 696 | 696 | Upgrade
|
| Additional Paid-In Capital | 812 | 812 | 812 | 812 | 812 | 812 | Upgrade
|
| Retained Earnings | 8,721 | 8,554 | 8,128 | 10,398 | 11,257 | 11,662 | Upgrade
|
| Treasury Stock | -1,136 | -1,136 | -1,135 | -1,135 | -1,135 | -1,135 | Upgrade
|
| Comprehensive Income & Other | 1 | 1 | 5 | 1 | 6 | 3 | Upgrade
|
| Shareholders' Equity | 9,094 | 8,927 | 8,506 | 10,772 | 11,636 | 12,038 | Upgrade
|
| Total Liabilities & Equity | 12,245 | 12,344 | 12,431 | 14,655 | 15,685 | 17,441 | Upgrade
|
| Total Debt | 1,460 | 1,816 | 2,354 | 2,032 | 2,557 | 3,918 | Upgrade
|
| Net Cash (Debt) | 3,364 | 2,927 | 1,605 | 2,785 | 3,094 | 1,745 | Upgrade
|
| Net Cash Growth | 76.96% | 82.37% | -42.37% | -9.99% | 77.31% | -23.67% | Upgrade
|
| Net Cash Per Share | 889.60 | 774.03 | 424.43 | 736.48 | 818.18 | 461.45 | Upgrade
|
| Filing Date Shares Outstanding | 3.78 | 3.78 | 3.78 | 3.78 | 3.78 | 3.78 | Upgrade
|
| Total Common Shares Outstanding | 3.78 | 3.78 | 3.78 | 3.78 | 3.78 | 3.78 | Upgrade
|
| Working Capital | 6,710 | 6,377 | 6,263 | 6,545 | 7,540 | 7,861 | Upgrade
|
| Book Value Per Share | 2404.88 | 2360.72 | 2249.36 | 2848.59 | 3077.07 | 3183.35 | Upgrade
|
| Tangible Book Value | 9,010 | 8,834 | 8,506 | 10,457 | 11,290 | 11,516 | Upgrade
|
| Tangible Book Value Per Share | 2382.66 | 2336.12 | 2249.36 | 2765.29 | 2985.57 | 3045.31 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.